Ch 1_Clinical Caveats

Clinical Caveats

In the field of learning and attention issues, brain imaging technology is still considered to be only a research tool. No brain imaging technology has been validated by the research community for clinical use in lieu of behavioral evaluations to diagnose either ADHD or dyslexia.

There is tremendous variability from one person to the next in terms of brain anatomy and brain function. (The same is also true when it comes to people’s genomes—even identical twins don’t have identical DNA!) Any differences that might serve as diagnostic markers need to be tested in large-scale studies and replicated by other researchers before brain scans can be used to reliably identify dyslexia in clinical settings.